Replacement of miR-155 Elicits Tumor Suppressive Activity and Antagonizes Bortezomib Resistance in Multiple Myeloma

Aberrant expression of microRNAs (miRNAs) has been associated to the pathogenesis of multiple myeloma (MM). While miR-155 is considered a therapeutic target in several malignancies, its role in MM is still unclear. The analysis of miR-155 expression indicates its down-regulation in MM patient-derive...

Descripción completa

Detalles Bibliográficos
Autores principales: Amodio, Nicola, Gallo Cantafio, Maria Eugenia, Botta, Cirino, Agosti, Valter, Federico, Cinzia, Caracciolo, Daniele, Ronchetti, Domenica, Rossi, Marco, Driessen, Christoph, Neri, Antonino, Tagliaferri, Pierosandro, Tassone, Pierfrancesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406286/
https://www.ncbi.nlm.nih.gov/pubmed/30781685
http://dx.doi.org/10.3390/cancers11020236

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406286/
https://www.ncbi.nlm.nih.gov/pubmed/30781685
http://dx.doi.org/10.3390/cancers11020236

Ejemplares similares